Delivery/task order for FDA/sanhafl biomerieux IDIQ contract
Ended Awarded Last action
- Contract number
- 75F40126F19053
- Awardee
-
Biomerieux Inc. UEI HCNVCMEG9NL6
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $24,844
Award facts
- Contract value 100% obligated
- $24,844.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Alameda, CA 94502, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $24,844.38 firm fixed-price delivery order to Biomerieux Inc. on April 13, 2026, with an ultimate completion date of August 20, 2026. This delivery order is issued under an existing FDA/Sanhafl Biomerieux Indefinite Delivery/Indefinite Quantity (IDIQ) contract and requires performance at Biomerieux's facility in Alameda, California. The award carries no set-aside designation, reflecting Biomerieux's status as a specialized sole-source provider of proprietary diagnostic technologies. Biomerieux, which operates under the doing-business-as name Vitek Systems, Inc., is a global leader in in vitro diagnostics and microbiological testing solutions.
Biomerieux maintains an extensive portfolio of federal diagnostic supply contracts exceeding $30 million in total ceiling value across multiple agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and National Institutes of Health. The company specializes in manufacturing advanced diagnostic equipment, reagents, test kits, and laboratory technologies, with particular expertise in microorganism identification, antibiotic susceptibility testing, and molecular pathogen detection. Under this delivery order and its parent IDIQ vehicle, Biomerieux provides critical diagnostic platforms and consumables that support infectious disease testing and clinical laboratory operations across federal healthcare agencies, positioning it as a vital supplier of specialized laboratory capabilities to the government sector.
Quick answers
Who was awarded contract 75F40126F19053?
75F40126F19053 was awarded to Biomerieux Inc. by Food and Drug Administration (Department of Health and Human Services) on April 13, 2026.
How much is contract 75F40126F19053 worth?
The government has obligated $24,844 on 75F40126F19053.
Is contract 75F40126F19053 an order under another contract?
Yes. 75F40126F19053 is a delivery order under 75F40121D00021, an indefinite delivery contract.
Was contract 75F40126F19053 competed?
The extent of competition for 75F40126F19053 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award